Genomics and Epigenomics Shared Resource
GESR Home | Services & Fees | Educational Resources | Publications | Schedule
Publications2003
Ahonen, T. J., J. Xie, M. J. LeBaron, J. Zhu, M. Nurmi, K. Alanen, H. Rui, and M. T. Nevalainen. 2003. Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells. J Biol Chem 278:27287-27292.
Chepko, G., and R. B. Dickson. 2003. Ultrastructure of the putative stem cell niche in rat mammary epithelium. Tissue Cell 35:83-93.
Fu, M., M. Rao, C. Wang, T. Sakamaki, J. Wang, D. Di Vizio, X. Zhang, C. Albanese, S. Balk, C. Chang, S. Fan, E. Rosen, J. J. Palvimo, O. A. Janne, S. Muratoglu, M. L. Avantaggiati, and R. G. Pestell. 2003. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23:8563-8575.
Johnson, M. D., N. Kenney, A. Stoica, L. Hilakivi-Clarke, B. Singh, G. Chepko, R. Clarke, P. F. Sholler, A. A. Lirio, C. Foss, R. Reiter, B. Trock, S. Paik, and M. B. Martin. 2003. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081-1084.
Kagan, B. L., R. T. Henke, R. Cabal-Manzano, G. E. Stoica, Q. Nguyen, A. Wellstein, and A. T. Riegel. 2003. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res 63:1696-1705.
Lee, C., and T. Waldman. 2003. Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341. Cancer Biol Ther 2:700-701.
Li, M., S. Ren, M. T. Tilli, J. A. Flaws, R. Lubet, C. J. Grubbs, and P. A. Furth. 2003. Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity. Oncogene 22:2568-2572.
Oberst, M. D., C. A. Williams, R. B. Dickson, M. D. Johnson, and C. Y. Lin. 2003. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem 278:26773-26779.
Ray, R., R. Cabal-Manzano, A. R. Moser, T. Waldman, L. M. Zipper, A. Aigner, S. W. Byers, A. T. Riegel, and A. Wellstein. 2003. Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis. Cancer Res 63:8085-8089.
Shah, S., A. Hecht, R. Pestell, and S. W. Byers. 2003. Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem 278:48137-48145.
Song, L. N., R. Herrell, S. Byers, S. Shah, E. M. Wilson, and E. P. Gelmann. 2003. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol 23:1674-1687.
Wang, C., N. Pattabiraman, J. N. Zhou, M. Fu, T. Sakamaki, C. Albanese, Z. Li, K. Wu, J. Hulit, P. Neumeister, P. M. Novikoff, M. Brownlee, P. E. Scherer, J. G. Jones, K. D. Whitney, L. A. Donehower, E. L. Harris, T. Rohan, D. C. Johns, and R. G. Pestell. 2003. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 23:6159-6173.
2004
Bouras, T., M. P. Lisanti, and R. G. Pestell. 2004. Caveolin-1 in breast cancer. Cancer Biol Ther 3:931-941.
D'Amico, M., K. Wu, M. Fu, M. Rao, C. Albanese, R. G. Russell, H. Lian, D. Bregman, M. A. White, and R. G. Pestell. 2004. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res 64:4122-4130.
Hernandez, E. M., C. H. Chan, B. Xu, V. Notario, and J. R. Richert. 2004. Role of an internal ribosome entry site in the translational control of the human transcription factor Sp3. Int J Oncol 24:719-724.
Isaacs, C., L. R. Cavalli, Y. Cohen, M. Pennanen, L. K. Shankar, M. Freedman, B. Singh, M. Liu, A. Gallagher, J. D. Rone, R. B. Dickson, D. Sidransky, and B. R. Haddad. 2004. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. Breast Cancer Res Treat 84:99-105.
Kim, J. S., C. Lee, A. Foxworth, and T. Waldman. 2004. B-Raf is dispensable for K-Ras-mediated oncogenesis in human cancer cells. Cancer Res 64:1932-1937.
Koehler, N. K., C. Y. Yang, J. Varady, Y. Lu, X. W. Wu, M. Liu, D. Yin, M. Bartels, B. Y. Xu, P. P. Roller, Y. Q. Long, P. Li, M. Kattah, M. L. Cohn, K. Moran, E. Tilley, J. R. Richert, and S. Wang. 2004. Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein. J Med Chem 47:4989-4997.
Kumar, D., P. Gokhale, C. Broustas, D. Chakravarty, I. Ahmad, and U. Kasid. 2004. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 23:612-616.
Li, W., H. Amri, H. Huang, C. Wu, and V. Papadopoulos. 2004. Gene and protein profiling of the response of MA-10 Leydig tumor cells to human chorionic gonadotropin. J Androl 25:900-913.
Moran, K. M., R. H. Crusio, C. H. Chan, M. C. Grekova, and J. R. Richert. 2004. Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis. Gene 341:235-247.
Nishanian, T. G., J. S. Kim, A. Foxworth, and T. Waldman. 2004. Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol Ther 3:667-675.
Peck, J. W., E. T. Bowden, and P. D. Burbelo. 2004. Structure and function of human Vps20 and Snf7 proteins. Biochem J 377:693-700.
Song, L. N., M. Coghlan, and E. P. Gelmann. 2004. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol Endocrinol 18:70-85.
2005
Abaan, O. D., A. Levenson, O. Khan, P. A. Furth, A. Uren, and J. A. Toretsky. 2005. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis. Oncogene 24:2715-2722.
Akula, N., and N. Pattabiraman. 2005. A systematic search method for the identification of tightly packed transmembrane parallel alpha-helices. J Biomol Struct Dyn 22:625-634.
Asatiani, E., W. X. Huang, A. Wang, E. Rodriguez Ortner, L. R. Cavalli, B. R. Haddad, and E. P. Gelmann. 2005. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 65:1164-1173.
Bae, I., J. K. Rih, H. J. Kim, H. J. Kang, B. Haddad, A. Kirilyuk, S. Fan, M. L. Avantaggiati, and E. M. Rosen. 2005. BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle 4:1641-1666.
Bouker, K. B., T. C. Skaar, R. B. Riggins, D. S. Harburger, D. R. Fernandez, A. Zwart, A. Wang, and R. Clarke. 2005. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26:1527-1535.
Bouras, T., M. Fu, A. A. Sauve, F. Wang, A. A. Quong, N. D. Perkins, R. T. Hay, W. Gu, and R. G. Pestell. 2005. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem 280:10264-10276.
Chepko, G., R. Slack, D. Carbott, S. Khan, L. Steadman, and R. B. Dickson. 2005. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. Tissue Cell 37:393-412.
Ching, K. H., A. E. Kisailus, and P. D. Burbelo. 2005. The role of SPECs, small Cdc42-binding proteins, in F-actin accumulation at the immunological synapse. J Biol Chem 280:23660-23667.
Di Giovanni, S., A. De Biase, A. Yakovlev, T. Finn, J. Beers, E. P. Hoffman, and A. I. Faden. 2005. In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem 280:2084-2091.
Fan, S., M. Gao, Q. Meng, J. J. Laterra, M. H. Symons, S. Coniglio, R. G. Pestell, I. D. Goldberg, and E. M. Rosen. 2005. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24:1749-1766.
Frech, M. S., E. D. Halama, M. T. Tilli, B. Singh, E. J. Gunther, L. A. Chodosh, J. A. Flaws, and P. A. Furth. 2005. Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 65:681-685.
Fu, M., M. Rao, T. Bouras, C. Wang, K. Wu, X. Zhang, Z. Li, T. P. Yao, and R. G. Pestell. 2005. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 280:16934-16941.
Fu, M., C. Wang, M. Rao, X. Wu, T. Bouras, X. Zhang, Z. Li, X. Jiao, J. Yang, A. Li, N. D. Perkins, B. Thimmapaya, A. L. Kung, A. Munoz, A. Giordano, M. P. Lisanti, and R. G. Pestell. 2005. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem 280:29728-29742.
LeBaron, M. J., J. Xie, and H. Rui. 2005. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol Cancer 4:6.
Li, H., Y. Zhang, A. Glass, T. Zellweger, E. Gehan, L. Bubendorf, E. P. Gelmann, and M. T. Nevalainen. 2005. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clin Cancer Res 11:5863-5868.
Mani, A., and E. P. Gelmann. 2005. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23:4776-4789.
McDonnell, K., E. T. Bowden, R. Cabal-Manzano, B. Hoxter, A. T. Riegel, and A. Wellstein. 2005. Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. Lab Invest 85:747-755.
Ramljak, D., L. J. Romanczyk, L. J. Metheny-Barlow, N. Thompson, V. Knezevic, M. Galperin, A. Ramesh, and R. B. Dickson. 2005. Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther 4:537-546.
Riggins, R. B., A. H. Bouton, M. C. Liu, and R. Clarke. 2005. Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. Vitam Horm 71:201-237.
Rosen, E. M., S. Fan, and C. Isaacs. 2005. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr Relat Cancer 12:533-548.
Sadowsky, J. D., M. A. Schmitt, H. S. Lee, N. Umezawa, S. Wang, Y. Tomita, and S. H. Gellman. 2005. Chimeric (alpha/beta + alpha)-peptide ligands for the BH3-recognition cleft of Bcl-XL: critical role of the molecular scaffold in protein surface recognition. J Am Chem Soc 127:11966-11968.
Song, L. N., and E. P. Gelmann. 2005. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. J Biol Chem 280:37853-37867.
Sultan, A. S., J. Xie, M. J. LeBaron, E. L. Ealley, M. T. Nevalainen, and H. Rui. 2005. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746-760.
Suy, S., J. B. Mitchell, A. Samuni, S. Mueller, and U. Kasid. 2005. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Cancer 103:1302-1313.
Tilli, M. T., R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel. 2005. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. Mol Endocrinol 19:644-656.
Tirado, O. M., S. Mateo-Lozano, and V. Notario. 2005. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity. Oncogene 24:3348-3357.
Uren, A., S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, R. Schlegel, and J. A. Toretsky. 2005. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res 65:6199-6206.
Uren, A., and J. A. Toretsky. 2005. Pediatric malignancies provide unique cancer therapy targets. Curr Opin Pediatr 17:14-19.
Wang, C., S. Fan, Z. Li, M. Fu, M. Rao, Y. Ma, M. P. Lisanti, C. Albanese, B. S. Katzenellenbogen, P. J. Kushner, B. Weber, E. M. Rosen, and R. G. Pestell. 2005. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res 65:6557-6567.
2006
Pirollo, K. F., J. Dagata, P. Wang, M. Freedman, A. Vladar, S. Fricke, L. Ileva, Q. Zhou, and E. H. Chang. 2006. A tumor-targeted nanodelivery system to improve early MRI detection of cancer. Mol Imaging 5:41-52.
Shajahan AN, Wang A, Decker M, Minshall RD, Liu MC, Clarke R. (2006) Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity. J Biol Chem. (Epub).
Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM. (2006) Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene. (Epub).
Zhu Y, Wang A, Liu MC, Zwart A, Lee RY, Gallagher A, Wang Y, Miller WR, Dixon JM, Clarke R. (2006) Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. Int J Oncol. 29(6):1581-9.
Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T. (2006) Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA. Mol Cell Biol. 27(2):662-77. Epub 2006 Oct 23. PMID: 17060456 [PubMed - in process]
Hilakivi-Clarke L, Shajahan A, Yu B, de Assis S. (2006) Differentiation of mammary gland as a mechanism to reduce breast cancer risk. J Nutr. 136(10):2697S-9S.
Han W, Zhang T, Yu H, Foulke JG, Tang CK. (2006) Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII. Cancer Biol Ther. 5(10):1361-8.
Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, Weissman AM, Schlegel R, Wellstein A, Riegel AT. (2006) E6AP Mediates Regulated Proteasomal Degradation of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 in Immortalized Cells. Cancer Res. 1;66(17):8680-6.
Yu B, Khan G, Foxworth A, Huang K, Hilakivi-Clarke L. (2006) Maternal dietary exposure to fiber during pregnancy and mammary tumorigenesis among rat offspring. Int J Cancer. 119(10):2279-86.
Katiyar P, Ma Y, Fan S, Pestell RG, Furth PA, Rosen EM. (2006) Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nucl Recept Signal. Epub
Toretsky JA, Erkizan V, Levenson A, Abaan OD, Parvin JD, Cripe TP, Rice AM, Lee SB, Ãœren A. (2006) Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. Cancer Res. 66(11):5574-81.
Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T, Pestell RG, Avantaggiati ML. (2006) Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol. 173(4):533-44.
de Assis S, Khan G, Hilakivi-Clarke L. (2006) High birth weight increases mammary tumorigenesis in rats. Int J Cancer. 119(7):1537-46.
Kang HJ, Kim HJ, Kim SK, Barouki R, Cho CH, Khanna KK, Rosen EM, Bae I. (2006) BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells. J Biol Chem. 281(21):14654-62.
Xie Z, Yuan H, Yin Y, Zeng X, Bai R, Glazer RI. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. BMC Cancer. 6:77.
de Assis S, Wang M, Goel S, Foxworth A, Helferich W, Hilakivi-Clarke L. (2006) Excessive weight gain during pregnancy increases carcinogen-induced mammary tumorigenesis in Sprague-Dawley and lean and obese Zucker rats. J Nutr. 136(4):998-1004.
Kang HJ, Kim HJ, Rih JK, Mattson TL, Kim KW, Cho CH, Isaacs JS, Bae I. (2006) BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J Biol Chem. 281(19):13047-56.
Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. (2006) In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate. 66(7):708-17.
Tassi E, Henke RT, Bowden ET, Swift MR, Kodack DP, Kuo AH, Maitra A, Wellstein A. (2006) Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res. 66(2):1191-8.
Pirollo KF, Zon G, Rait A, Zhou Q, Yu W, Hogrefe R, Chang EH. (2006) Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther. 17(1):117-24.
VandenBussche CJ, Dakshanamurthy S, Posch PE, Hurley CK (2006) A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J Immunol. 2006 Oct 15;177(8):5347-57. PMID: 17015720 [PubMed - indexed for MEDLINE]
Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL.. p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev. 2006;15(1):80-5.
2007
Avvisato CL, Yang X, Shah S, Hoxter B, Li W, Gaynor R et al. Mechanical force modulates global gene expression and beta-catenin signaling in colon cancer cells. J Cell Sci 2007; 120(Pt 15):2672-2682.
Bouker, K. B., Skaar, T. C., Harburger, D. S., Riggins, R. B., Fernandez, D. R., Zwart, A., and Clarke, R. The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines. Cancer Genet Cytogenet, 175: 61-64, 2007.
Byers S, Shah S. Vitamin D and the regulation of Wnt/beta-catenin signaling and innate immunity in colorectal cancer. Nutr Rev 2007; 65(8 Pt 2):S118-S120.
Casimiro, M., Rodriguez, O., Pootrakul, L., Fricke, S., Ostrowski, M., Hung, MC., Rabbani, S., Datar, R., Cote, R., Pestell, R., and Albanese, C. ErbB-2 induces the cyclin D1 gene in prostate epithelial Cells in vitro and in vivo. Cancer Research. 2007 May 1 7(9):4364-72
Dakshanamurthy S., Kim, M., Brown, M., Byers, S. Identification of novel Angiogenesis inhibitors using a multi-step computer aided approach. (Bioorg. Med.Chem.Lett. 2007 Aug 15;17(16):4551-6
Gomez, B. P., Riggins, R. B., Shajahan, A. N., Klimach, U., Wang, A., Crawford, A. C., Zhu, Y., Zwart, A., Wang, M., and Clarke, R. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J, 21: 4013-4027, 2007.
Ji Y, Shah S, Soanes K, Islam MN, Hoxter B, Biffo S, Heslip T, Byers S. Eukaryotic initiation factor 6 selectively regulates Wnt signaling and beta-catenin protein synthesis. Oncogene advance online publication, 30 July 2007; doi:10.1038/sj.onc.1210667.
Jiang, S., Li, P., Lee, S. L., Lin, C. Y., Long, Y. Q., Johnson, M. D., Dickson, R. B., and Roller, P. P. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase. Org Lett, 9: 9-12, 2007.
Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T (2007). Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA. Mol Cell Biol 27(2): 662-677.
Li, F., Li, L., Qin, X., Zhu, B., Tanowitz, H., Albanese, C (corresponding author), Chen, L. Apelin-induced smooth muscle cell proliferation: the regulation of cyclin D1. 2007. Frontiers in Bioscience (In Press)
Li, P., Jiang, S., Lee, S. L., Lin, C. Y., Johnson, M. D., Dickson, R. B., Michejda, C. J., and Roller, P. P. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1. J Med Chem, 50: 5976-5983, 2007.
Pishvaian MJ, Byers SW. Biomarkers of WNT signaling. Cancer Biomark 2007; 3(4-5):263-274.
2008
Wang, x, Yin, Y., Yuan, H., Sakamaki, T, Okano, H, and Glazer, R. I. Musashil modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Mol Cell Biol . 2008. In Press
Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM (2007). Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene 26(20):2925-2938.
Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y, Byers SW (2008) Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS ONE. 2008 Jul 16;3(7):e2714. PMID: 18628953.
Steiner NK, Dakshanamurthy S, Vandenbussche CJ, Hurley CK (2008) Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5. Immunogenetics. 2008 Aug 6. [Epub ahead of print]
Vandenbussche CJ, Mulrooney TJ, Frazier WR, Dakshanamurthy S, Hurley CK (2008) Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun. 2008 Nov 13. [Epub ahead of print] PMID: 19005473.
Glazer RI, Wang XY, Yuan H, Yin Y (2008) Musashi1: a stem cell marker no longer in search of a function. Cell Cycle. 2008 Sep;7(17):2635-9. Epub 2008 Sep 30. PMID: 18719393.
Wang XY, Yin Y, Yuan H, Sakamaki T, Okano H, Glazer RI (2008) Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Mol Cell Biol. 2008 Jun;28(11):3589-99. Epub 2008 Mar 24. PMID: 18362162
Veselik DJ, Divekar S, Dakshanamurthy S, Storchan GB, Turner JM, Graham KL, Huang L, Stoica A, Martin MB. Activation of estrogen receptor-alpha by the anion nitrite. Cancer Res. 2008 May 15;68(10):3950-8. PMID: 18483281.
Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer. 2008 Jan;8(1):37-49. Review. PMID: 18097463.
Coticchia CM, Revankar CM, Deb TB, Dickson RB, Johnson MD. Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat. 2008 Jun 28. [Epub ahead of print].
Deb TB, Coticchia CM, Barndt R, Zuo H, Dickson RB, Johnson MD. Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation. Am J Physiol Cell Physiol. 2008 Aug;295(2):C365-77. Epub 2008 Jun 18.
Fereshteh MP, Tilli MT, Kim SE, Xu J, O'Malley BW, Wellstein A, Furth PA, Riegel AT. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res. 2008 May 15;68(10):3697-706.
Wang M, Yu B, Westerlind K, Strange R, Khan G, Patil D, Boeneman K, Hilakivi-Clarke L. Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland. Breast Cancer Res Treat. 2008 May 31. [Epub ahead of print] PMID: 18516675.
Chen K, Fallen S, Abaan HO, Hayran M, Gonzalez C, Wodajo F, MacDonald T, Toretsky JA, Ãœren A. Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival. Pediatr Blood Cancer. 2008 Sep;51(3):349-55. PMID: 18465804.
Oh AS, Lahusen JT, Chien CD, Fereshteh MP, Zhang X, Dakshanamurthy S, Xu J, Kagan BL, Wellstein A, Riegel AT. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Mol Cell Biol. 2008 Sep 2. [Epub ahead of print] PMID: 18765637.
Fereshteh MP, Tilli MT, Kim SE, Xu J, O'Malley BW, Wellstein A, Furth PA, Riegel AT. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res. 2008 May 15;68(10):3697-706.
Kang HJ, Kim HJ, Cho CH, Hu Y, Li R, Bae I. BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR. Cancer Chemother Pharmacol. 2008 Feb 8. [Epub ahead of print] PMID: 18259752.
Kang HJ, Kim HJ, Kwon SH, Kang BD, Eling TE, Lee SH, Bae I. BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity. Cancer Chemother Pharmacol. 2008 Sep;62(4):689-97. Epub 2007 Dec 12.
Pirollo KF, Rait A, Zhou Q, Zhang XQ, Zhou J, Kim CS, Benedict WF, Chang EH. Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo. Clin Cancer Res. 2008 Apr 1;14(7):2190-8. PMID: 18381961.
Mi L, Xiao Z, Hood BL, Dakshanamurthy S, Wang X, Govind S, Conrads TP, Veenstra TD, Chung FL. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem. 2008 Aug 8;283(32):22136-46. Epub 2008 Jun 3.
Tan D, Goerlitz DS, Dumitrescu RG, Han D, Seillier-Moiseiwitsch F, Spernak SM, Orden RA, Chen J, Goldman R, Shields PG. Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis. 2008;29(6):1170-7.
Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1082-7
Tao MH, Shields PG, Nie J, Millen A, Ambrosone CB, Edge SB, Krishnan SS, Marian C, Xie B, Winston J, Vito D, Trevisan M, Freudenheim JL. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat. 2008 May 8 [Epub ahead of print] PMID: 18463976.
